Skip to main content
Advertisement
  • Loading metrics

Correction: Evaluation of nitazoxanide treatment following triclabendazole failure in an outbreak of human fascioliasis in Upper Egypt

  • Haidi Karam-Allah Ramadan,
  • Waleed Attia Hassan,
  • Nahed Ahmed Elossily,
  • Alzahraa Abdelraouf Ahmad,
  • Adnan Ahmed Mohamed,
  • Alaa Soliman Abd- Elkader,
  • Eman M. Nagiub Abdelsalam,
  • Hani M. J. Khojah

In the methodology section of the abstract the term “pathological” was used incorrectly and should be “biochemical” instead. The corrected sentence reads: “The remaining cases received additional doses of TCBZ with complete clinical, biochemical, and radiological resolution.”

There is a typographical error in the footnote of Table 5. In the updated Table 5, the reference range for platelet count in the footnote has been updated to 150,000–450,000/µL.

thumbnail
Table 5. Laboratory data of the studied patients who received first line triclabendazole.

https://doi.org/10.1371/journal.pntd.0008443.t001

References

  1. 1. Ramadan HK-A, Hassan WA, Elossily NA, Ahmad AA, Mohamed AA, Abd- Elkader AS, et al. (2019) Evaluation of nitazoxanide treatment following triclabendazole failure in an outbreak of human fascioliasis in Upper Egypt. PLoS Negl Trop Dis 13(9): e0007779. https://doi.org/10.1371/journal.pntd.0007779 pmid:31553716